Deutsche Bank
JSPR icon

Deutsche Bank’s Jasper Therapeutics JSPR Stock Holding History

Deutsche Bank’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-160,000
Closed -$381K – 3680
2025
Q3 		$381K Hold
160,000
– – ﹤0.01% 2690
2025
Q2 		$888K Sell
160,000
-9,350
-6% -$46K ﹤0.01% 2159
2025
Q1 		$728K Sell
169,350
-1,345
-0.8% -$8.95K ﹤0.01% 2305
2024
Q4 		$3.65M Buy
170,695
+39,436
+30% +$821K ﹤0.01% 1493
2024
Q3 		$2.47M Sell
131,259
-63,176
-32% -$1.26M ﹤0.01% 1625
2024
Q2 		$4.41M Buy
+194,435
New +$4.66M ﹤0.01% 1300

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Deutsche Bank's JSPR Position: Q4 2025 in Review

Deutsche Bank sold out of Jasper Therapeutics (JSPR) in Q4 2025, closing a stake of 160,000 shares — an estimated $381K sold.

Deutsche Bank first reported a position in JSPR in Q2 2024 and held it in 6 quarters. The position peaked at $4.41M in Q2 2024. 55 funds tracked by Wall St. Rank hold JSPR as of Q4 2025.

  • Deutsche Bank reported no remaining Jasper Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Deutsche Bank sold 160,000 Jasper Therapeutics shares in Q4 2025, an estimated $381K.
  • Deutsche Bank first reported a position in Jasper Therapeutics in Q2 2024 and held it in 6 quarters.
  • Deutsche Bank's Jasper Therapeutics position peaked at $4.41M in Q2 2024.
  • 55 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2025.

Based on Deutsche Bank's 13F filing for Q4 2025, filed 11 Feb 2026.